CVS Health Corporation (CVS)
Stock Of The Day: Historic Technical Analysis Lesson In CVS
Shares of CVS Health Corporation CVS are trading lower on Thursday. This move could break important support.
CVS Might Just Be the Last Drugstore Stock. Should It Be Broken Up?
The pharmacy stock would stand by itself if Walgreens goes private. Wall Street weighs in on the worth of the company's parts.
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's why the CVS Health stock price may rebound in 2025
CVS Health stock price continued to underperform the market this year as the pharmacy industry faced significant challenges. It has dropped by over 30% this year, while the S&P 500 and Nasdaq 100 indices have soared to a record high.
CVS' High Utilization & MBR to Cut 2024 Profits: Is the Stock a Sell?
The persistently elevated utilization of medical services is significantly putting pressure on CVS Health's Health Care Benefits segment.
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Why Is CVS Health (CVS) Down 0.4% Since Last Earnings Report?
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
Cramer's Stop Trading: CVS Health
CNBC's Jim Cramer explains why he is keeping an eye on shares of CVS Health.
Analyst: "Buy" Underperforming CVS Health Stock
Shares of healthcare giant CVS Health Corp (NYSE:CVS) are 1.5% higher before the bell, after a bull note at Deutsche Bank.
Deutsche upgrades CVS to Buy with earnings, valuation at trough
Deutsche Bank analyst George Hill upgraded CVS Health to Buy from Hold with an unchanged price target of $66. The firm believes both the company's earnings and multiple are now likely near trough levels. CVS has taken steps to turn the company towards improving profitability, the analyst tells investors in a research note. Following an analysis of the managed care segment, Deutsche thinks an earnings recovery is both achievable and will outpace Street expectations.
Is CVS Health Stock a Buy?
CVS Health (CVS -0.18%) has been a long-running migraine for shareholders, struggling to manage rising medical costs that have impacted profitability. At the time of writing, the stock is down 25% year to date and more than 40% lower than its record-high price of $101.29 set in February 2022.
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
